XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 207.2 $ 147.1
Trade and other accounts receivable (less allowances of $9.6 million and $7.7 million respectively) 305.2 334.6
Inventories (less allowances of $27.2 million and $27.1 million respectively):    
Finished goods 234.0 259.3
Raw materials 97.5 113.8
Total inventories 331.5 373.1
Prepaid expenses 7.7 14.1
Prepaid income taxes 10.7 3.3
Other current assets 1.4 0.4
Total current assets 863.7 872.6
Net property, plant and equipment 244.6 220.9
Operating lease right-of-use assets 42.5 45.3
Goodwill 357.9 358.8
Net book amount at September 30 47.8 45.0
Deferred tax assets 5.9 5.9
Pension asset 49.7 48.1
Other non-current assets 6.5 7.1
Total assets 1,618.6 1,603.7
Current liabilities:    
Accounts payable 146.1 165.3
Accrued liabilities 165.1 202.9
Current portion of operating lease liabilities 13.1 13.9
Current portion of plant closure provisions 4.7 5.3
Current portion of accrued income taxes 15.2 18.4
Total current liabilities 344.2 405.8
Operating lease liabilities, net of current portion 29.4 31.4
Plant closure provisions, net of current portion 51.1 51.9
Accrued income taxes, net of current portion 11.6 21.0
Unrecognized tax benefits 14.1 13.4
Deferred tax liabilities 26.4 26.2
Pension liabilities and post-employment benefits 12.2 12.2
Other non-current liabilities 1.5 1.4
Total liabilities 490.5 563.3
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 358.9 354.1
Treasury stock (4,688,514 and 4,788,966 shares at cost, respectively) (94.2) (95.4)
Retained earnings 1,008.3 924.2
Accumulated other comprehensive loss (147.9) (145.2)
Total Innospec stockholders' equity 1,125.4 1,038.0
Non-controlling interest 2.7 2.4
Total equity 1,128.1 1,040.4
Total liabilities and equity $ 1,618.6 $ 1,603.7